FLEXIBILITY MEASUREMENTS OF INJECTABLE GELS
20200072721 · 2020-03-05
Assignee
Inventors
Cpc classification
A61K9/06
HUMAN NECESSITIES
A61K9/0024
HUMAN NECESSITIES
A61L27/58
HUMAN NECESSITIES
G01N11/165
PHYSICS
G01N11/162
PHYSICS
G01N2011/0026
PHYSICS
A61K9/0019
HUMAN NECESSITIES
A61L27/50
HUMAN NECESSITIES
G01N11/142
PHYSICS
G01N2400/40
PHYSICS
A61K47/36
HUMAN NECESSITIES
International classification
A61L27/58
HUMAN NECESSITIES
Abstract
A process for evaluating rheological characteristics of an injectable gel including measuring the flexibility, wherein the flexibility is evaluated by measuring the strain at the crossover point of the amplitude sweep. The process may include subjecting an injectable gel to oscillating mechanical stresses to determine G and G as a function of strain () in an amplitude sweep, determining the crossover point as the point at which G and G have the same value, determining the strain .sub.cross at the crossover point, and determining the flexibility of the injectable gel as .sub.cross or proportional to .sub.cross. Further, a method of comparison of dermal fillers by measuring their flexibility and a method of evaluation of dermal filler behavior in human skin by measuring the flexibility.
Claims
1. Process for evaluating rheological characteristics of an injectable gel comprising measuring the flexibility, wherein the flexibility is evaluated by measuring the strain at the crossover point of the amplitude sweep, wherein the crossover point of the amplitude sweep is the point where the Elastic Modulus G and the viscous modulus G have the same value, and wherein the process comprises subjecting an injectable gel to oscillating mechanical stresses to determine G and G as a function of strain () in an amplitude sweep, determining the crossover point at which G and G have the same value, determining the strain .sub.cross at the crossover point, and determining the flexibility of the injectable gel as .sub.cross or proportional to .sub.cross.
2. (canceled)
3. (canceled)
4. Process according to claim 1, wherein the amplitude sweep is performed by increasing the amount of deformation of the gel until a change in both G and G are observed.
5. Process according to claim 1, wherein the step of determining the crossover point as the point at which G and G have the same value is performed by plotting G and G as a function of the strain () and selecting the crossover point as the point where the plot of G and the plot of G intersect.
6. Process according to claim 4, wherein the step of determining G and G as a function of strain () comprises a step of performing a frequency sweep at a fixed strain before performing the amplitude sweep.
7. Process according to claim 1, wherein the crossover point is a point outside the linear viscoelastic region (LVR) of the injectable gel.
8. Process according to claim 1, wherein the flexibility is measured in percentage (%).
9. Process according to claim 1, further comprising the step of comparing the evaluated flexibility with a flexibility value of a reference gel, and if the evaluated flexibility is above said flexibility value of a reference gel, concluding that the injectable gel is more flexible than the reference gel.
10. Process according to claim 9, wherein the step of concluding comprises concluding that the injectable gel is more suitable than the reference gel for being implanted at regions in the face that are subjected to movement.
11. Process according to claim 1, wherein the amplitude sweep is performed at a frequency of between 0.5 Hz-1.5 Hz.
12. Process according to claim 1 where the injectable gel is a dermal filler comprising crosslinked hyaluronic acid.
13. Method of comparison of dermal fillers by measuring their flexibility according to claim 1.
14. Method according to claim 13, wherein the method comprises measuring the flexibility of a plurality of different candidate dermal fillers, comparing the measured flexibility between the plurality of candidate dermal fillers, and selecting a dermal filler of the plurality of dermal fillers as a dermal filler suitable for injection based on the comparison.
15. Method according to claim 14, wherein the gel having the highest flexibility value is selected as a dermal filler suitable for injection in the facial area.
16. Method of evaluation of dermal filler behavior in human skin by measuring the flexibility according to claim 1.
17. A method for determining a flexibility value of an injectable gel comprising the steps of receiving input data of the elastic modulus G and the viscous modulus G as a function of the strain of said gel, determining the strain .sub.cross as the strain at which the elastic modulus G and the viscous modulus G have the same value, determining the flexibility value of the injectable gel as .sub.cross or a value proportional to .sub.cross.
18. A method according to claim 17, further comprising the step of comparing the flexibility value of the injectable gel with a reference flexibility value.
19. A method according to claim 17, further comprising the step of displaying the flexibility value on a computer screen.
20. A computer program product comprising computer-executable components for causing a device to perform the steps recited in claim 17 when the computer-executable components are run on a processing unit included in the device.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
DETAILED DESCRIPTION OF THE INVENTION
[0076] The present invention relates to a process to characterize an injectable gel, and more preferably a dermal filler gel, by measuring a new parameter, the flexibility.
[0077] The flexibility of the gel is measured and in the below description and examples denoted as XStrain. The higher the value is, the higher the flexibility of the gel. This new parameter can be used to characterize different dermal fillers and their different behaviors in skin after injection.
[0078] To verify if a difference in flexibility could be detected using a scientific test methodology, rheology was employed. For the first time, the filler flexibility can be measured. As evaluated from the cross-over point between G and G in the amplitude sweep results, a difference in flexibility was evident from the difference in the deformation (strain, ) at which the cross-over point occurred. The flexibility value obtained is here denoted XStrain. The value of XStrain demonstrates how much deformation the tested material can withstand before changing from a solid-like to a liquid-like behavior, i.e. going from basically reversible to basically irreversible deformation. The XStrain measured can be considered a flexibility index of a material.
[0079] The firmness of a product, measured as G using rheometry, is performed under nearly static conditions. The deformations used in these measurements are very small, in order to keep within the linear viscoelastic region (LVR), the region where the stress changes linearly with deformation. These measurements are normally performed as a frequency sweep. In order to determine a suitable level of deformation to use in the frequency sweep, an amplitude sweep is performed, where the amount of deformation is increased until a change in the results is observed, indicating the end of the LVR. A level of deformation where the measured firmness is stable is chosen for the frequency sweep. However, the data from the amplitude sweep can be further evaluated. When the edge of the LVR is reached, it means that the deformation is so large that the material can no longer retain its original shape, and starts behaving more like a liquid than a solid. In rheology, this point is often referred to as the yield point. A typical example of a material having a noticeable yield point is tomato ketchup, which moves frustratingly little until the bottle is shaken enough, resulting in the delivered portion of ketchup being larger than intended.
[0080] Though there is a consensus on what the yield point is, the definition on where in the amplitude sweep this can be found may vary. Generally, as soon as there is a change in the signal, e.g. in the level of G, this would indicate the endpoint of the LVR. Since there is always some noise in the signal, the change has to be of a certain magnitude in order to be correctly detected. When analyzing very soft samples giving a weaker signal, a larger deviation has to be allowed in order not to incorrectly detect noise as the end of the LVR (
[0081] An endpoint that is much easier to pinpoint exactly is the cross-over point, where G and G intersect (
[0082] Flexibility values can be in the range of 0.1% to 20000% according to the type of dermal filler requested use.
[0083] In a specific embodiment, when dermal filler are injected into the face to correct age related effects, the flexibility parameter gives the ability to natural animation without the implant showing under the skin. Being more of less flexible, the dermal filler hydrogel follows the movement of the face and gives the ability to preserve the natural expressions of the face.
EXPERIMENTAL EXAMPLES
[0084] The following non-limiting examples will further illustrate the present invention. In these examples, the flexibility of different dermal fillers comprising hyaluronic acid was determined. The following examples are describing how flexibility can be measured through evaluation of the cross-over point from the amplitude sweep and help to characterize dermal filler products.
Example 1: Measurement of Flexibility
[0085] a) Injectable Gels
[0086] The Optimal Balance Technology (OBT) products from Galderma are dermal filler differing in the amount of crosslinker used. This results in materials with different rheological properties. There is a need to understand their behavior by characterizing their rheological properties, through this measurement of the new parameter: flexibility. The OBT family of dermal filler products has previously been found to cover a large span of G values as measured from a frequency sweep at small deformations. The purpose of this study was to investigate evaluation of the cross-over point in the amplitude sweep as a measure of flexibility for the OBT family of products. This measurement can characterize dermal fillers and explain their differentiating features and behavior in the skin.
[0087] b) Test Methods
[0088] The rheology measurement was performed in a sequence including a relaxation time of 30 min, a frequency sweep from 10 to 0.1 Hz at 0.1% strain, followed by an amplitude sweep from 0.1 to 10000% (0.001 to 100) strain at 1 Hz. The gap was 1 mm using a PP25 measuring system at 25 C. The frequency sweep was evaluated for G, G at 0.1 Hz. The amplitude sweep was first evaluated at 0.1% strain in order to verify that the applied frequency sweep strain was within the linear viscoelastic range. Secondly the strain was evaluated at the crossover point of the amplitude sweep, i.e. the point where G and G have the same value (
[0089] c) Test Results
[0090] Each product of the OBT range (Table 1) was analyzed for the xStrain value derived from the amplitude sweep (
TABLE-US-00001 TABLE 1 List of analyzed products and test results: Product xStrain (%) Restylane Defyne 761 Restylane Volyme 908 Restylane Kysse 930 Restylane Refyne 1442 Restylane Fynesse 2221
[0091] d) Discussion
[0092] Since the different products in the OBT family are crosslinked in exactly the same way, differing only in the amount of crosslinker used, it can be assumed that the main difference in the crosslinking structure is the distance between crosslinking points (
[0093] The person skilled in the art realizes that the present invention by no means is limited to the preferred embodiments described above. On the contrary, many modifications and variations are possible within the scope of the appended claims. Additionally, variations to the disclosed embodiments can be understood and effected by the skilled person in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims. In the claims, the word comprising does not exclude other elements or steps, and the indefinite article a or an does not exclude a plurality. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measured cannot be used to advantage.